A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1 Journal Article


Authors: Loizou, E.; Banito, A.; Livshits, G.; Ho, Y. J.; Koche, R. P.; Sánchez-Rivera, F. J.; Mayle, A.; Chen, C. C.; Kinalis, S.; Bagger, F. O.; Kastenhuber, E. R.; Durham, B. H.; Lowe, S. W.
Article Title: A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1
Abstract: Mutations in the TP53 tumor suppressor gene are common in many cancer types, including the acute myeloid leukemia (AML) subtype known as complex karyotype AML (CK-AML). Here, we identify a gain-of-function (GOF) Trp53 mutation that accelerates CK-AML initiation beyond p53 loss and, surprisingly, is required for disease maintenance. The Trp53R172H mutation (TP53R175H in humans) exhibits a neomorphic function by promoting aberrant self-renewal in leukemic cells, a phenotype that is present in hematopoietic stem and progenitor cells (HSPC) even prior to their transformation. We identify FOXH1 as a critical mediator of mutant p53 function that binds to and regulates stem cell-associated genes and transcriptional programs. Our results identify a context where mutant p53 acts as a bona fide oncogene that contributes to the pathogenesis of CK-AML and suggests a common biological theme for TP53 GOF in cancer. SIGNIFICANCE: Our study demonstrates how a GOF p53 mutant can hijack an embryonic transcription factor to promote aberrant self-renewal. In this context, mutant Trp53 functions as an oncogene to both initiate and sustain myeloid leukemia and suggests a potential convergent activity of mutant Trp53 across cancer types.This article is highlighted in the In This Issue feature, p. 813. ©2019 American Association for Cancer Research.
Journal Title: Cancer Discovery
Volume: 9
Issue: 7
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2019-07-01
Start Page: 962
End Page: 979
Language: English
DOI: 10.1158/2159-8290.Cd-18-1391
PUBMED: 31068365
PROVIDER: scopus
PMCID: PMC6606372
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Scott W Lowe
    249 Lowe
  2. Richard Patrick Koche
    176 Koche
  3. Chi-Chao   Chen
    19 Chen
  4. Benjamin Heath Durham
    116 Durham
  5. Evangelia   Loizou
    6 Loizou
  6. Yu-jui Ho
    41 Ho
  7. Allison Mayle
    4 Mayle